Product Overview
[Drug Name]
Generic Name: Piracetam Dispersible Tablets
Trade Name: Dongbei
English Name: Piracetam Dispersible Tablets
Chinese Pinyin: Piracetan Fensan Pian
[Ingredients]
The main ingredient of this product is piracetam. Chemical Name: 2-Oxy-1-pyrrolidinylacetamide. Molecular Formula: C6H10N2O2. Molecular Weight: 142.16
[Properties]
This product is a white tablet.
[Indications]
1. For memory loss after cerebrovascular accident and mild brain trauma; 2. To promote intellectual development in children with mild mental retardation.
[Dosage and Administration]
Can be taken directly orally or dissolved in water. The typical dosage for adults is 0.8 grams (one tablet) three times daily. In severe cases, the dosage can be increased to 1.6 grams (two tablets) three times daily. A course of treatment is 3 to 6 weeks.
[Adverse Reactions]
1. Central nervous system adverse reactions include nervousness, excitement, irritability, hyperactivity, dizziness, headache, sleep disturbances (insomnia, hypersomnia), and depression. These symptoms are mild and unrelated to dosage. 2. Gastrointestinal symptoms include nausea, abdominal discomfort, anorexia, bloating, abdominal pain, weight gain, and diarrhea. The severity of these symptoms is directly related to dosage. These symptoms disappear after discontinuation of medication. 3. Mild liver impairment, manifested as mild elevation of transaminases, may occasionally occur, but this is unrelated to dosage. 4. Rash may occasionally occur.
[Contraindications]
This product is contraindicated in patients with extrapyramidal disorders or Huntington's chorea to avoid exacerbating symptoms. It is contraindicated in patients with severe hepatic or renal impairment.
[Precautions]
Use with caution in patients with mild to moderate hepatic or renal impairment and reduce the dose appropriately.
[Special Use]
Precautions for Pediatric Use:
This product is contraindicated in neonates. This dosage form is not suitable for children.
Precautions During Pregnancy and Lactation:
This product readily crosses the placenta and is therefore contraindicated in pregnant women. It is unclear whether this product is excreted in breast milk during lactation, so it should be avoided in lactating women.
Precautions for Elderly Patients:
Elderly patients may experience decreased physiological function and should be treated with caution. If used, appropriate dosages should be selected as appropriate.
[Drug Interactions]
1. When used in combination with warfarin, this product may prolong the prothrombin time and induce platelet aggregation inhibition. 2. In patients receiving anticoagulant therapy, when piracetam is used concomitantly, special attention should be paid to clotting time to prevent bleeding risks and to adjust the dosage and administration of the anticoagulant medication.
[Pharmacological Actions]
Piracetam is a cyclic derivative of r-aminobutyric acid. Animal studies have shown that piracetam can prevent or protect animals from retrograde amnesia caused by hypoxia. Furthermore, piracetam significantly antagonizes the inhibitory effects of barbiturates on the central nervous system, suggesting that it may increase intracellular ATP and cell membrane excitability.
[Storage]
Store in a sealed, dry place.
[Specification]
0.8g
[Packaging]
0.8g x 30s/bottle.
[Expiry Date]
Tentatively 24 months
[Approval Number]
National Medicine Standard H20030997
[Manufacturer]
Company Name: Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd.
